Hi, everyone!
Are you using Twitter? If so, I'd like to pass along our new account to you: @454Sequencing.
As we wrote in our inaugural tweet, our goal is connecting with you, our users - as well as with folks who are interested in our technology but not (yet!) using it, by sharing questions, experiences and your success stories. I'm sure we'll figure out the best and most useful things to post over time. Generally speaking, we'll use it to share breaking news, publications and other tidbits about 454 Sequencing. Let's see where it goes from there!
We've got some exciting announcements coming soon...so go ahead and follow us on Twitter and keep up to date!
See you online!
-454Sequencing
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...